Techniques for prevention of atrial fibrillation

• US 8,204,591 B2
• Filed: 01/24/2007
• Issued: 06/19/2012
• Est. Priority Date: 05/23/2002
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: BioControl Medical (B.C.M) Ltd.
• Inventors: Ben-David, Tamir, Ben-Ezra, Omry, Cohen, Ehud
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): MALAMUD, DEBORAH LESLIE
• Application Number:
  US11/657,784
• Publication Number:
  US 20070179543A1
• Time in Patent Office: 1,973 Days
• Field of Search: 607 1- 2, 607/5, 607/7, 607/9, 607/11, 607 14- 15, 607115-118
• US Class Current: 607/14
• CPC Class Codes: A61N 1/0556 Cuff electrodes
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/36117 for treating hypertension
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/395 for treating atrial fibrillation
• CPC Class Codes: A61N 1/3962 in combination with another heart therapy
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

A method is provided, including identifying that a subject is at risk of suffering from atrial fibrillation (AF). Responsively to the identifying, a risk of an occurrence of an episode of the AF is reduced by applying an electrical current to a site of the subject selected from the group consisting of: a vagus nerve, a sinoatrial (SA) node fat pad, a pulmonary vein, a carotid artery, a carotid sinus, a coronary sinus, a vena cava vein, a jugular vein, an azygos vein, an innominate vein, and a subclavian vein, and configuring the current to stimulate autonomic nervous tissue in the site. Other embodiments are also described.

Claims

1. A method comprising:

applying an electrical current, at a first strength on average, to a site of a subject containing parasympathetic nervous tissue;

configuring the current to stimulate the nervous tissue in the site;

performing at least one action selected from the group consisting of;

sensing an occurrence of an episode of atrial fibrillation (AF), and predicting an imminent episode of the AF; and

responsively to the performing, applying the current at a second strength on average during a strength reduction period having a duration of at least one minute, which second strength is less than the first strength.

2. The method according to claim 1, comprising, upon a conclusion of the strength reduction period, configuring the current to reduce a heart rate of the subject, upon sensing that the episode of the AF has not terminated and that the subject has an elevated heart rate.

3. The method according to claim 1, wherein applying the current at the second strength comprises withholding applying the current.

4. The method according to claim 1, wherein applying the current at the first strength comprises applying the current at the first strength at least once during each of seven consecutive 48-hour periods.

5. The method according to claim 1, wherein the site is selected from the group consisting of:

a vagus nerve, an epicardial fat pad, a sinoatrial (SA) node fat pad, an atrioventricular (AV) node fat pad, a pulmonary vein, a carotid artery, a carotid sinus, a coronary sinus, a vena cava vein, a jugular vein, an azygos vein, an innominate vein, and a subclavian vein, and wherein applying the current comprises applying the current to the selected site.

6. The method according to claim 1, wherein performing comprises sensing the occurrence of the episode of the AF, and wherein applying the current at the second strength comprises during the strength reduction period comprises applying the current at the second strength during the episode.

7. The method according to claim 6, wherein applying the current at the second strength responsively to the performing comprises applying the second current at the second strength upon sensing the occurrence of the episode of the AF.

8. The method according to claim 1, wherein performing comprises predicting the imminent episode of the AF.

9. The method according to claim 8, wherein applying the current at the second strength responsively to the performing comprises applying the second current at the second strength upon predicting the imminent episode of the AF.

10. The method according to claim 1, wherein the duration of the strength reduction period is at least one hour, and wherein applying the current at the second strength on average comprises applying the current at the second strength on average during the strength reduction period having the duration of at least one hour.

11. The method according to claim 1, comprising identifying that the subject is at risk of suffering from AF, wherein applying the current at the first strength comprises, responsively to the identifying, reducing a risk of the occurrence of the episode of the AF by applying the current at the first strength.

12. The method according to claim 11, wherein applying the current at the first strength comprises commencing applying at least 24 hours after the identifying.

13. The method according to claim 1, wherein applying the current at the first strength comprises detecting normal sinus rhythm (NSR) of the subject, and applying the current at the first strength during the detected NSR.

14. The method according to claim 1, wherein applying the current at the first strength does not comprise configuring the current to achieve a target heart rate or a target heart rate range of the subject.

15. Apparatus comprising:

an electrode device, configured to be coupled to a site of the subject at risk of suffering from atrial fibrillation (AF), the site containing parasympathetic nervous tissue; and

a control unit, configured to;

drive the electrode device to apply an electrical current to the site at a first strength on average,

configure the current to stimulate the nervous tissue in the site,

perform at least one action selected from the group consisting of;

sensing an occurrence of an episode of atrial fibrillation (AF), and predicting an imminent episode of the AF, and

responsively to the performance, apply the current at a second strength on average during a strength reduction period having a duration of at least one minute, which second strength is less than the first strength.

16. The apparatus according to claim 15, wherein the control unit is configured to, upon a conclusion of the strength reduction period, configure the current to reduce a heart rate of the subject, upon sensing that the episode of the AF has not terminated and that the subject has an elevated heart rate.

17. The apparatus according to claim 15, wherein the control unit is configured to apply the current at the second strength by withholding applying the current.

18. The apparatus according to claim 15, wherein the control unit is configured to apply the current at the first strength at least once during each of seven consecutive 48-hour periods.

19. The apparatus according to claim 15, wherein the site is selected from the group consisting of:

a vagus nerve, an epicardial fat pad, a sinoatrial (SA) node fat pad, a pulmonary vein, an atrioventricular (AV) node fat pad, a carotid artery, a carotid sinus, a coronary sinus, a vena cava vein, a jugular vein, an azygos vein, an innominate vein, and a subclavian vein, and wherein the electrode device is configured to be coupled to the selected site.

20. The apparatus according to claim 15, wherein the control unit is configured to sense the occurrence of the episode of the AF, and to apply the current at the second strength during the episode.

21. The apparatus according to claim 20, wherein the control unit is configured to apply the current at the second strength upon sensing the occurrence of the episode of the AF.

22. The apparatus according to claim 15, wherein the control unit is configured to predict the imminent episode of the AF.

23. The apparatus according to claim 22, wherein the control unit is configured to apply the current at the second strength upon predicting the imminent episode of the AF.

24. The apparatus according to claim 15, wherein the duration of the strength reduction period is at least one hour, and wherein the control unit is configured to apply the current at the second strength on average during the strength reduction period having the duration of at least one hour.

25. The apparatus according to claim 15, wherein the control unit is configured to reduce a risk of the occurrence of the episode of the AF by driving the electrode device to apply the current at the first strength.

26. The apparatus according to claim 15, wherein the control unit is configured to detect normal sinus rhythm (NSR) of the subject, and to drive the electrode device to apply the current at the first strength during the detected NSR.

27. The apparatus according to claim 15, wherein the control unit is not configured to configure the current to achieve a target heart rate or a target heart rate range of the subject.